These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 17100370

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Low dose of transdermal estradiol gel for treatment of symptomatic postmenopausal women: a randomized controlled trial.
    Simon JA, Bouchard C, Waldbaum A, Utian W, Zborowski J, Snabes MC.
    Obstet Gynecol; 2007 Mar; 109(3):588-96. PubMed ID: 17329509
    [Abstract] [Full Text] [Related]

  • 3. The effect of transdermal and vaginal estrogen therapy on markers of postmenopausal estrogen status.
    Gupta P, Ozel B, Stanczyk FZ, Felix JC, Mishell DR.
    Menopause; 2008 Mar; 15(1):94-7. PubMed ID: 17882008
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Uterine and vaginal effects of unopposed ultralow-dose transdermal estradiol.
    Johnson SR, Ettinger B, Macer JL, Ensrud KE, Quan J, Grady D.
    Obstet Gynecol; 2005 Apr; 105(4):779-87. PubMed ID: 15802405
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. One-year endometrial safety evaluation of a continuous combined transdermal matrix patch delivering low-dose estradiol-norethisterone acetate in postmenopausal women.
    Samsioe G, Dvorak V, Genazzani AR, Hamann B, Heikkinen J, Mueck AO, Suzin J, Kawakami FT, Ferreira A, Sun D, Arguinzoniz M.
    Maturitas; 2007 Jun 20; 57(2):171-81. PubMed ID: 17317046
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics of estradiol and of estrone during application of a new 7-day estradiol transdermal patch with active matrix.
    Setnikar I, Rovati LC, Vens-Cappell B, Hilgenstock C.
    Arzneimittelforschung; 1998 Mar 20; 48(3):275-85. PubMed ID: 9553686
    [Abstract] [Full Text] [Related]

  • 9. A study of 17beta-estradiol-regulated genes in the vagina of postmenopausal women with vaginal atrophy.
    Cotreau MM, Chennathukuzhi VM, Harris HA, Han L, Dorner AJ, Apseloff G, Varadarajan U, Hatstat E, Zakaria M, Strahs AL, Crabtree JS, Winneker RC, Jelinsky SA.
    Maturitas; 2007 Dec 20; 58(4):366-76. PubMed ID: 17997058
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of low-dose estradiol vaginal tablets in the treatment of atrophic vaginitis: a randomized controlled trial.
    Bachmann G, Lobo RA, Gut R, Nachtigall L, Notelovitz M.
    Obstet Gynecol; 2008 Jan 20; 111(1):67-76. PubMed ID: 18165394
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of the route of estrogen administration on insulinlike growth factor-I, IGF binding protein-3, and insulin resistance in healthy postmenopausal women: results from a randomized, controlled study.
    Davis SR, Stuckey BG, Norman RJ, Papalia MA, Drillich A, Bell RJ.
    Menopause; 2008 Jan 20; 15(6):1065-9. PubMed ID: 18806686
    [Abstract] [Full Text] [Related]

  • 13. The effect of transdermal estradiol on hormone and metabolic dynamics over a six-week period.
    Haas S, Walsh B, Evans S, Krache M, Ravnikar V, Schiff I.
    Obstet Gynecol; 1988 May 20; 71(5):671-6. PubMed ID: 3357653
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effects of intranasal 17beta-estradiol administration on serum bioactive interleukin-6 and C-reactive protein levels in healthy postmenopausal women.
    Rachoń D, Suchecka-Rachoń K, Hak Ł, Myśliwska J.
    Menopause; 2006 May 20; 13(5):840-5. PubMed ID: 16894332
    [Abstract] [Full Text] [Related]

  • 16. Lowest effective transdermal 17beta-estradiol dose for relief of hot flushes in postmenopausal women: a randomized controlled trial.
    Bachmann GA, Schaefers M, Uddin A, Utian WH.
    Obstet Gynecol; 2007 Oct 20; 110(4):771-9. PubMed ID: 17906008
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics of estradiol and of estrone during repeated transdermal or oral administration of estradiol.
    Setnikar I, Rovati LC, Vens-Cappell B, Hilgenstock C.
    Arzneimittelforschung; 1996 Aug 20; 46(8):766-73. PubMed ID: 9125276
    [Abstract] [Full Text] [Related]

  • 18. An open-label randomized trial to determine the most effective regimen of vaginal estrogen to reduce the prevalence of atrophic changes reported in postmenopausal cervical smears.
    Bateson DJ, Weisberg E.
    Menopause; 2009 Aug 20; 16(4):765-9. PubMed ID: 19407678
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Transdermal estradiol gel 0.1% for the treatment of vasomotor symptoms in postmenopausal women.
    Hedrick RE, Ackerman RT, Koltun WD, Halvorsen MB, Lambrecht LJ.
    Menopause; 2009 Aug 20; 16(1):132-40. PubMed ID: 18971794
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.